Skip to main content

letter

. 1980 Dec;33(12):1221–1222. doi: 10.1136/jcp.33.12.1221

Antiphagocytic effect of Pseudomonas aeruginosa exopolysaccharide.

R W Ruhen, P G Holt, J M Papadimitriou

PMCID: PMC1146384 PMID: 6778898

1221

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Burns M. W., May J. R. Bacterial precipitins in serum of patients with cystic fibrosis. Lancet. 1968 Feb 10;1(7537):270–272. doi: 10.1016/s0140-6736(68)90121-9. [DOI] [PubMed] [Google Scholar]
Doggett R. G., Harrison G. M., Carter R. E. Mucoid Pseudomonas aeruginosa in patients with chronic illnesses. Lancet. 1971 Jan 30;1(7692):236–237. doi: 10.1016/s0140-6736(71)90973-1. [DOI] [PubMed] [Google Scholar]
Govan J. R. Mucoid strains of Pseudomonas aeruginosa: the influence of culture medium on the stability of mucus production. J Med Microbiol. 1975 Nov;8(4):513–522. doi: 10.1099/00222615-8-4-513. [DOI] [PubMed] [Google Scholar]
Holt P. G. Alveolar macrophages. I. A simple technique for the preparation of high numbers of viable alveolar macrophages from small laboratory animals. J Immunol Methods. 1979;27(2):189–198. doi: 10.1016/0022-1759(79)90264-3. [DOI] [PubMed] [Google Scholar]
Schwarzmann S., Boring J. R. Antiphagocytic Effect of Slime from a Mucoid Strain of Pseudomonas aeruginosa. Infect Immun. 1971 Jun;3(6):762–767. doi: 10.1128/iai.3.6.762-767.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]

ACTIONS

RESOURCES